Skip to Main Content

Paper Details

The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling.
Cancers (Basel)
18
2019
AKT, ERK, Extracellular Signal Regulated Kinase, Glioblastoma, Glioblastoma cell lines, MLN4924, MLN4924 sensitive cells, NAE, NAE1, NEDD8, NEDD8-activating enzyme, PKB, Patient, Patient-Derived Glioblastoma Cells, Protein kinase B, UBA3, brain tumor, glioblastoma, glioblastoma cell line models, glioblastoma cell lines, glioblastoma stem cells, human, normal human astrocytes, patient, patient-, patient-derived glioblastoma stem cells, patient-derived stem cells, patients, sensitive cells
Author NameAffiliation
Hyemi ShinInstitute for Refractory Cancer Research, Samsung Medical Center
Jeong-Woo OhInstitute for Refractory Cancer Research, Samsung Medical Center
Jeong-Woo OhSamsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University
  • 1 - 9

Datasets

Release 1.2